EUVIMEDEUVIMED entdecken
Kohortenstudie

Limited clinical role of blood eosinophil levels in early life atopic disease: A mother–child cohort study

Signe Kjeldgaard Jensen iD, Mathias Elsner Melgaard iD, Casper-Emil Tingskov Pedersen iD, Luo Yang iD, Nilo Vahman iD, Jacob P Thyssen iD, Ann-Marie M Schoos iD, Jakob Stokholm iD, Hans Bisgaard iD, Bo Chawes iD, Klaus Bønnelykke iD

Pediatric Allergy and Immunology · 2023

DOI: 10.1111/pai.14050 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pediatric Allergy and Immunology, 2023. Verfasst von Signe Kjeldgaard Jensen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Department of Pediatrics, Herlev and Gentofte Hospital, University of Copenhagen, Cop…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Asthma, Rhinitis, Allergic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Lundbeck Foundation, Ministry of Health, Danish Council for Strategic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Blood eosinophil count is a well‐established biomarker of atopic diseases in older children and adults. However, its predictive role for atopic diseases in preschool children is not well established.

Objective

To investigate the association between blood eosinophil count in children and development of atopic diseases up to age 6 years.

Methods

We investigated blood eosinophil count at age 18 months and 6 years in relation to recurrent wheeze/asthma, atopic dermatitis, allergic rhinitis, and allergic sensitization during the first 6 years of life in the two Copenhagen Prospective Studies on Asthma in Childhood cohorts ( n = 1111). Blood eosinophil count was investigated in association with remission of existing atopic disease, current atopic disease, and later development of atopic disease.

Results

Blood eosinophil count at 18 months was not associated with current wheezing/asthma or atopic dermatitis, while blood eosinophil count at age 6 years was associated with increased occurrence of current wheezing/asthma (OR = 1.1; 1.04–1.16, p = .0005), atopic dermatitis (OR = 1.06; 1.01–1.1, p = .02), and allergic rhinitis (OR = 1.11; 1.05–1.18, p = .0002). Blood eosinophil count at 18 months did not predict persistence or development of recurrent wheeze/asthma or atopic dermatitis at age 6 years.

Conclusion

Blood eosinophil count at 18 months was not associated with current wheezing/asthma or atopic dermatitis and did not predict persistence or development of disease. This implies a limited clinical role of blood eosinophil levels in early‐life atopic disease and questions the clinical value of blood eosinophil counts measured in toddlers as a predictive biomarker for subsequent atopic disease in early childhood.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicAsthmaRhinitis, AllergicAdultHumansChild, PreschoolChildInfantCohort StudiesEosinophilsProspective StudiesRespiratory SoundsBiomarkersMother-Child Relations

Stichwörter der Autor:innen

allergic rhinitisasthmaatopic dermatitisatopic diseaseeosinophiliaperipheral blood eosinophil countpolygenic risk scorepredictorrecurrent wheezesensitization

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Department of Pediatrics, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Pediatrics, Slagelse Hospital, Slagelse, Denmark.
  • Section of Microbiology and Fermentation, Department of Food Science, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Signe Kjeldgaard Jensen, Mathias Elsner Melgaard, Casper-Emil Tingskov Pedersen, Luo Yang, Nilo Vahman, Jacob P Thyssen, Ann-Marie M Schoos, Jakob Stokholm, Hans Bisgaard, Bo Chawes, Klaus Bønnelykke

Förderung

  • Lundbeck Foundation
  • Ministry of Health
  • Danish Council for Strategic Research
  • China Scholarship Council
  • Lundbeckfonden
  • Strategiske Forskningsråd

Zitieren

APA

Jensen, S. K., Melgaard, M. E., Pedersen, C. T., Yang, L., Vahman, N., Thyssen, J. P., Schoos, A. M., Stokholm, J., Bisgaard, H., Chawes, B., & Bønnelykke, K. (2023). Limited clinical role of blood eosinophil levels in early life atopic disease: A mother–child cohort study. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14050

Vancouver

Jensen SK, Melgaard ME, Pedersen CT, Yang L, Vahman N, Thyssen JP, et al. Limited clinical role of blood eosinophil levels in early life atopic disease: A mother–child cohort study. Pediatric Allergy and Immunology. 2023. doi:10.1111/pai.14050

BibTeX
@article{Jensen2023,
  author = {Jensen, Signe Kjeldgaard and Melgaard, Mathias Elsner and Pedersen, Casper-Emil Tingskov and Yang, Luo and Vahman, Nilo and Thyssen, Jacob P and Schoos, Ann-Marie M and Stokholm, Jakob and Bisgaard, Hans and Chawes, Bo and Bønnelykke, Klaus},
  title = {Limited clinical role of blood eosinophil levels in early life atopic disease: A mother–child cohort study},
  journal = {Pediatric Allergy and Immunology},
  year = {2023},
  doi = {10.1111/pai.14050}
}
Kostenlos starten →